Company · CIK 0001991792 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
CG Oncology, Inc. · CGON
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 SForm 4 → | Sep 17, 4:30 pm EDT | Leonard E PostDirector | 1,000 | $72.98 | $72,980 | 0 | −100% | 10b5-1 |
| Sep 15, 2026 MForm 4 → | Sep 17, 4:30 pm EDT | Leonard E PostDirector | 1,000 | $0.60 | $600 | 1,000 | — | 10b5-1 |
| Aug 14, 2026 SForm 4 → | Aug 18, 4:30 pm EDT | Leonard E PostDirector | 1,000 | $74.54 | $74,540 | 0 | −100% | 10b5-1 |
| Aug 14, 2026 MForm 4 → | Aug 18, 4:30 pm EDT | Leonard E PostDirector | 1,000 | $0.60 | $600 | 1,000 | — | 10b5-1 |
| Jul 15, 2026 SForm 4 → | Jul 17, 4:15 pm EDT | Leonard E PostDirector | 1,000 | $71.17 | $71,170 | 0 | −100% | 10b5-1 |
| Jul 15, 2026 MForm 4 → | Jul 17, 4:15 pm EDT | Leonard E PostDirector | 1,000 | $0.60 | $600 | 1,000 | — | 10b5-1 |
| Jul 10, 2026 SForm 4 → | Jul 14, 4:15 pm EDT | James MulayDirector | 24,165 | $75.16 | $1,816,241 | 0 | −100% | 10b5-1 |
| Jul 10, 2026 MForm 4 → | Jul 14, 4:15 pm EDT | James MulayDirector | 24,165 | $26.63 | $643,514 | 24,165 | — | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 MForm 4 → | Sep 17, 4:30 pm EDT | Leonard E PostDirector | 1,000 | — | — | 103,077 | — | 10b5-1 |
| Aug 14, 2026 MForm 4 → | Aug 18, 4:30 pm EDT | Leonard E PostDirector | 1,000 | — | — | 104,077 | — | 10b5-1 |
| Jul 15, 2026 MForm 4 → | Jul 17, 4:15 pm EDT | Leonard E PostDirector | 1,000 | — | — | 105,077 | — | 10b5-1 |
| Jul 10, 2026 MForm 4 → | Jul 14, 4:15 pm EDT | James MulayDirector | 24,165 | — | — | 0 | — | 10b5-1 |